{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-026776","form_type":"8-K","ticker":"ASTC","cik":"0001001907","company_name":"ASTROTECH Corp","filed_at":"2022-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.141846+00:00","generated_at":"2026-06-21T22:00:44.837042+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Astrotech reports Q1 FY2023 revenue of $38K, authorizes $1M share repurchase","bullets":["Revenue $38K for Q1 FY2023, down from prior year due to shift from ETD to AgLAB-1000-D2 commercialization.","Cash and liquid investments total $48.9M, supporting R&D, organic growth, and potential acquisitions.","Board authorized $1M share repurchase program from Nov 17, 2022 through Nov 17, 2023.","BreathTech subsidiary contracts clinical research firm to collect breath samples; BreathTest-1000 shows discrimination ability.","AgLAB-1000-D2 field trials promising; first production run started and sales efforts underway."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-026776","json":"https://secwatch.observer/filing/0001437749-22-026776.json","markdown":"https://secwatch.observer/filing/0001437749-22-026776.md","text":"https://secwatch.observer/filing/0001437749-22-026776.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1001907/000143774922026776/0001437749-22-026776-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1001907/000143774922026776/astc20221107_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T22:00:44.837042+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"575f767066875c42cd98c48fd70f81cfa416a1f1","claim":"ASTROTECH Corp reported first quarter of fiscal year 2023, which ended September 30, 2022 results: revenue $38 thousand.","evidence_excerpt":"Revenue for the quarter totaled $38 thousand and was mainly related to ongoing maintenance services and sales of consumables for the TRACER 1000TM explosive trace detector (ETD).","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1001907/000143774922026776/0001437749-22-026776-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter of fiscal year 2023, which ended September 30, 2022"},{"label":"Revenue","value":"$38 thousand"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}